Paramethoxyethylamphetamine
Paramethoxyethylamphetamine (PMEA) is a psychoactive drug and research chemical belonging to the amphetamine class of compounds. It is closely related to other substances such as paramethoxyamphetamine (PMA) and methylenedioxymethamphetamine (MDMA), sharing similar chemical structures and effects. PMEA has been found to act as a serotonin, dopamine, and norepinephrine releasing agent, which contributes to its psychoactive properties. However, compared to its more famous relatives like MDMA, PMEA is less potent and has been less widely studied or used recreationally.
The synthesis and pharmacological effects of PMEA were first described in scientific literature in the late 20th century. Since then, it has been encountered sporadically in the illicit drug market, often misrepresented as MDMA or other more popular empathogens. This misidentification can lead to dangerous consequences due to the differing potencies and effects of these substances.
Effects[edit | edit source]
The effects of PMEA, as reported by users, can include euphoria, increased empathy and sociability, mild hallucinations, and altered sensory perception. However, due to its lower potency, the effects are generally less intense than those of MDMA. The risk of adverse effects, including neurotoxicity, hyperthermia, and cardiovascular problems, is also present, especially when taken in high doses or in combination with other substances.
Health Risks[edit | edit source]
The health risks associated with PMEA are not well-documented due to its rarity and limited use. However, as with other amphetamines, potential risks include addiction, serotonin syndrome, and long-term neurotoxic effects. The lack of research and information on PMEA makes it particularly risky, as the full extent of its effects and interactions with other drugs are not well understood.
Legal Status[edit | edit source]
The legal status of PMEA varies by country, but it is often controlled under laws targeting designer drugs and analogs of controlled substances. In many jurisdictions, it is illegal to manufacture, distribute, or possess PMEA without a license.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
